Concerns over Efficacy and Cost of Muscle Wasting Treatments
Concerns over Efficacy and Cost of Muscle Wasting Treatments
Two new medications for treating a rare and deadly neuromuscular disease have high prices and questionable efficacies, say scientists.
Concerns over Efficacy and Cost of Muscle Wasting Treatments
Concerns over Efficacy and Cost of Muscle Wasting Treatments

Two new medications for treating a rare and deadly neuromuscular disease have high prices and questionable efficacies, say scientists.

Two new medications for treating a rare and deadly neuromuscular disease have high prices and questionable efficacies, say scientists.

industry
New Drug Combo for ALS Slows Decline in Small Clinical Study
New Drug Combo for ALS Slows Decline in Small Clinical Study
Jef Akst | Sep 3, 2020
After six months, patients with fast-progressing amyotrophic lateral sclerosis who had received the experimental treatment had less loss of function than those who received a placebo.
Thousands of Coronavirus Infections Stemmed from a Biotech Event
Thousands of Coronavirus Infections Stemmed from a Biotech Event
Amanda Heidt | Aug 26, 2020
Officials had initially linked 97 cases to a single conference held by Biogen in February in Boston, but a new study tracking viral genomes suggests the number may be as high as 20,000.
It Takes Less Than 30 Days to Compost a Human Body
It Takes Less Than 30 Days to Compost a Human Body
Jef Akst | Feb 17, 2020
In a small trial of deceased volunteers, a Seattle-based company called Recompose demonstrates that its method for “natural organic reduction” of a human body completely breaks down soft tissue.
Opinion: Taxpayers Should Cover Portion of Patent Costs
Opinion: Taxpayers Should Cover Portion of Patent Costs
Paul R. Sanberg | Oct 9, 2019
Federal grant support for technology transfer at universities will strengthen the national innovation system.
California Seeks to Ban Chlorpyrifos-Containing Pesticides
California Seeks to Ban Chlorpyrifos-Containing Pesticides
Jef Akst | May 9, 2019
The state’s Environmental Protection Agency says that evidence of the chemical’s link to neurological problems in children is overwhelming.
Miracle Elixirs
Miracle Elixirs
Bob Grant | Mar 31, 2019
A long way into the quest to vanquish cancer, our ears strain to hear the words, “Cancer is cured”—a yearning that can cloud our judgment.
Industry Partners Extensively Involved in Trials They Fund
Industry Partners Extensively Involved in Trials They Fund
Catherine Offord | Oct 5, 2018
A new study suggests that sponsors downplay their influence when reporting trials carried out in collaboration with academic researchers.
Blue Rush: One Company Leads the Race to Own Marine Genetic Sequences
Blue Rush: One Company Leads the Race to Own Marine Genetic Sequences
Ruth Williams | Jun 6, 2018
Almost half of all patents relating to the genes of marine organisms belong to one large international corporation, BASF, a new study reveals.  
How to Successfully Collaborate with Industry
How to Successfully Collaborate with Industry
Ashley P. Taylor | Feb 28, 2018
In efforts to translate basic-science results into pharmaceuticals and other technologies, success cannot be taken for granted.